What is Altimmune's EV / sales?

Altimmune (ALT) reported EV / sales of 8,989.3× in Q4 2025.

How has Altimmune's EV / sales changed year-over-year?

Altimmune's EV / sales decreased by 62.4% year-over-year, from 23,876.1× to 8,989.3×.

What is the long-term trend for Altimmune's EV / sales?

Over 4 years (2020 to 2025), Altimmune's EV / sales has grown at a 284.7% compound annual growth rate (CAGR), from 41× to 8,989.3×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Altimmune ALT EV / sales

EV / sales at other companies

Eli LillyLLY

11.9×-4.0×

Merck & Co.MRK

5.2×+1.2×

Madrigal Pharmaceuticals, Inc.MDGL

10.7×-12.1×

Wave Life SciencesWVE

4.7×-2.1×

Delcath SystemsDCTH

3.1×-4.6×

MeiraGTx Holdings plcMGTX

8.7×-7.2×

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Calculated from Altimmune’s reported figures.

enterprise value/total revenue=8,989.3×

Based on the most recent quarter.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's EV / sales?: Altimmune (ALT) reported EV / sales of 8,989.3× in Q4 2025.
How has Altimmune's EV / sales changed year-over-year?: Altimmune's EV / sales decreased by 62.4% year-over-year, from 23,876.1× to 8,989.3×.
What is the long-term trend for Altimmune's EV / sales?: Over 4 years (2020 to 2025), Altimmune's EV / sales has grown at a 284.7% compound annual growth rate (CAGR), from 41× to 8,989.3×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.